In contrast, upregulation of three of hubs, including PIK3R3, GIGYF1, and BCL2L11 was considerably related to a favorable prognosis in HNSCC patients (log-rank test and HR p-values < 0.05). This evidence concerns the gene BCL2L11 and head and neck squamous cell carcinoma.